Locations:
Search IconSearch

Neurosciences

intravenous infusion line

Shorter Ocrelizumab Infusion Time for Multiple Sclerosis Does Not Affect Safety Profile

No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy

MRI of a patient with brain metastases
April 25, 2023/Cancer

Management of Lung Cancer Brain Metastases: An Update

We now have an expanded toolbox to extend survival and lessen treatment toxicity

23-NEU-3642023-CQD-Hero-650×450-button
April 18, 2023/Cancer

Clinical Trials for Brain and Spine Tumors: Challenges and Opportunities (Podcast)

Insights on leveraging collaboration and advocacy to develop and conduct needed trials

23-NEU-3739358-CQD-Hero-650×450

Markers of Metabolic Syndrome Linked to Cognitive Decline in MCI and Alzheimer’s

High plasma ApoA1 and TG/HDL-C ratio predict faster progression

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-NEU-3642022-CQD-Hero-650×450
April 4, 2023/Behavioral Health

Renewed Interest in Psychedelic Treatment for Behavioral Health Conditions (Podcast)

Research shows promise for use in therapeutic settings to manage depression, PTSD, anxiety and more

22-NEU-3482369-CQD-Hero-650×450
March 31, 2023/Neurosciences/Spine Care

Can Artificial Intelligence Point the Way to Better Spine Care?

A preview of Cleveland Clinic’s emerging AI platform for spine care decision-making

23-NEU-3627359-CQD-Hero-650×450

6 Things to Know About the Future Home of Our Neurological Institute

Designed for digitization, distance health, discovery and more

23-HVI-3529770 CQD 650×450
March 23, 2023/Cancer

Massive Spine and Retroperitoneal Sarcoma: A Case Study in Surgical Collaboration

Invasion of the lumbar spine and iliac vein made resection risky

23-NEU-3559064-CQD-Hero-650×450

Survey Suggests Opportunities to Curb ALS Diagnostic Delay Through Primary Care Education

PCPs reveal low levels of confidence in assessing for amyotrophic lateral sclerosis

BackPage 30 of 82Next

Advertisement

Ad